TD Asset Management
NVCR icon

TD Asset Management’s NovoCure NVCR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$343K Sell
19,248
-28,964
-60% -$516K ﹤0.01% 1152
2025
Q1
$859K Sell
48,212
-204,942
-81% -$3.65M ﹤0.01% 1093
2024
Q4
$7.54M Sell
253,154
-97,600
-28% -$2.91M 0.01% 707
2024
Q3
$5.48M Buy
350,754
+56,002
+19% +$874K ﹤0.01% 776
2024
Q2
$5.05M Buy
294,752
+13,252
+5% +$227K ﹤0.01% 764
2024
Q1
$4.4M Buy
281,500
+15,000
+6% +$234K ﹤0.01% 807
2023
Q4
$3.98M Buy
266,500
+56,400
+27% +$842K ﹤0.01% 817
2023
Q3
$3.39M Sell
210,100
-40,548
-16% -$655K ﹤0.01% 815
2023
Q2
$10.4M Buy
250,648
+11,177
+5% +$464K 0.01% 591
2023
Q1
$14.4M Buy
239,471
+130,291
+119% +$7.84M 0.02% 512
2022
Q4
$8.01M Sell
109,180
-15,700
-13% -$1.15M 0.01% 643
2022
Q3
$9.62M Buy
124,880
+1,000
+0.8% +$77.1K 0.01% 601
2022
Q2
$8.61M Buy
123,880
+15,200
+14% +$1.06M 0.01% 644
2022
Q1
$9M Buy
108,680
+46,816
+76% +$3.88M 0.01% 684
2021
Q4
$4.65M Buy
61,864
+5,106
+9% +$383K ﹤0.01% 888
2021
Q3
$6.59M Sell
56,758
-1,770
-3% -$206K 0.01% 759
2021
Q2
$9.01M Buy
58,528
+20,248
+53% +$3.12M 0.01% 679
2021
Q1
$5.06M Sell
38,280
-471
-1% -$62.3K 0.01% 815
2020
Q4
$6.71M Buy
38,751
+9,791
+34% +$1.69M 0.01% 708
2020
Q3
$3.22M Buy
28,960
+1,400
+5% +$156K ﹤0.01% 812
2020
Q2
$1.63M Buy
27,560
+400
+1% +$23.7K ﹤0.01% 927
2020
Q1
$1.83M Sell
27,160
-3,600
-12% -$242K ﹤0.01% 855
2019
Q4
$2.59M Sell
30,760
-13,600
-31% -$1.15M ﹤0.01% 871
2019
Q3
$3.32M Sell
44,360
-36,400
-45% -$2.72M 0.01% 784
2019
Q2
$5.11M Buy
80,760
+20,360
+34% +$1.29M 0.01% 681
2019
Q1
$2.91M Buy
60,400
+4,200
+7% +$202K ﹤0.01% 828
2018
Q4
$1.88M Buy
+56,200
New +$1.88M ﹤0.01% 923